Fig. 1From: A novel stability-indicating chromatographic quantification of the antiparkinsonian drug safinamide in its pharmaceutical formulation employing HPTLC densitometry and ion-pair HPLC–DADChemical structure of a Safinamide Mesylate (SAF), and b 4-Hydroxybenzaldehyde (4-HBD)Back to article page
